Kanser tedavisinde son y\u0131llarda geli\u015ftirilen yeni y\u00f6ntemler, kar\u0131n zar\u0131 (periton) metastaz\u0131 olan hastalara umut oluyor. Medicana Sa\u011fl\u0131k Grubu Genel Cerrahi B\u00f6l\u00fcm\u00fc\u2019nden Prof. Dr. Koray Topg\u00fcl, ge\u00e7mi\u015fte tedavisi olduk\u00e7a zor kabul edilen bu hastal\u0131kta HIPEC ve PIPAC ad\u0131 verilen modern uygulamalar sayesinde ya\u015fam s\u00fcresi ve ya\u015fam kalitesinde \u00f6nemli ilerlemeler sa\u011fland\u0131\u011f\u0131n\u0131 s\u00f6yledi.
\n
Kanser tedavisinde t\u0131bbi geli\u015fmeler h\u0131zla ilerlerken, kar\u0131n zar\u0131 (periton) metastaz\u0131 ya\u015fayan hastalar i\u00e7in yeni y\u00f6ntemler g\u00fcndeme geliyor. Medicana International \u0130zmir Hastanesi Genel Cerrahi Uzman\u0131 Prof. Dr. Koray Topg\u00fcl, HIPEC ve PIPAC gibi modern tedavi yakla\u015f\u0131mlar\u0131n\u0131n, uygun hasta gruplar\u0131nda ya\u015fam s\u00fcresini ve ya\u015fam kalitesini art\u0131rmada \u00f6nemli katk\u0131lar sa\u011flad\u0131\u011f\u0131n\u0131 belirtti. Bu y\u00f6ntemlerin her hastaya uygulanamayaca\u011f\u0131n\u0131, yaln\u0131zca uzman hekimlerin de\u011ferlendirmesi ve yetkin merkezlerde yap\u0131lmas\u0131 gerekti\u011fini vurgulad\u0131. Prof. Dr. Koray Topg\u00fcl, peritonun kar\u0131n i\u00e7indeki organlar\u0131 saran ve kar\u0131n duvar\u0131n\u0131 \u00f6rten ince bir zar oldu\u011funu hat\u0131rlatarak baz\u0131 kanserlerde t\u00fcm\u00f6r h\u00fccrelerinin bu zara tutunabildi\u011fini belirtti. Bu durumun periton metastaz\u0131 olarak adland\u0131r\u0131ld\u0131\u011f\u0131n\u0131 ifade eden Prof. Dr. Koray Topg\u00fcl, “Periton metastaz\u0131 en s\u0131k kolon, mide ve yumurtal\u0131k kanserlerinde g\u00f6r\u00fcl\u00fcr. Daha nadir olarak apendiks, pankreas, safra yollar\u0131 ve meme kanserlerinde de kar\u015f\u0131m\u0131za \u00e7\u0131kabilir” dedi.<\/p>\n
“Eskiden sa\u011fkal\u0131m 6 ay\u0131 ge\u00e7mezdi”
\n
Ge\u00e7mi\u015fte periton metastaz\u0131 geli\u015fen hastalarda yaln\u0131zca sistemik kemoterapi ya da palyatif cerrahinin uyguland\u0131\u011f\u0131n\u0131 s\u00f6yleyen Prof. Dr. Koray Topg\u00fcl, bu nedenle sa\u011fkal\u0131m\u0131n \u00e7o\u011fu zaman 6 ay\u0131 ge\u00e7medi\u011fini vurgulad\u0131. Ancak son y\u0131llarda geli\u015ftirilen y\u00f6ntemlerle bu tablonun de\u011fi\u015fti\u011fine dikkat \u00e7ekti. Prof. Dr. Koray Topg\u00fcl, HIPEC\u2019in (Hipertermik \u0130ntraperitoneal Kemoterapi) cerrahiyle t\u00fcm\u00f6rlerin temizlenmesinden sonra kar\u0131n bo\u015flu\u011funa 42-43 dereceye \u0131s\u0131t\u0131lm\u0131\u015f kemoterapi ila\u00e7lar\u0131n\u0131n verilmesiyle uyguland\u0131\u011f\u0131n\u0131 anlatt\u0131. Prof. Dr. Koray Topg\u00fcl, “Bu y\u00f6ntemle kemoterapi do\u011frudan t\u00fcm\u00f6r\u00fcn oldu\u011fu b\u00f6lgeye veriliyor. Is\u0131, kanser h\u00fccrelerini daha duyarl\u0131 hale getiriyor. Sistemik kemoterapiye g\u00f6re yan etkisi daha az, etkinli\u011fi daha fazlad\u0131r” dedi. Prof. Dr. Koray Topg\u00fcl, uygun se\u00e7ilmi\u015f kolon ve over kanseri hastalar\u0131nda HIPEC ile 5 y\u0131ll\u0131k sa\u011fkal\u0131m oranlar\u0131n\u0131n y\u00fczde 30-40\u2019a kadar \u00e7\u0131kt\u0131\u011f\u0131n\u0131 s\u00f6yledi.
\n
PIPAC\u2019\u0131n (Bas\u0131n\u00e7l\u0131 Aerosol Kemoterapisi) daha yeni bir y\u00f6ntem oldu\u011funu belirten Prof. Dr. Koray Topg\u00fcl, laparoskopik y\u00f6ntemle kar\u0131n bo\u015flu\u011funa girildi\u011fini ve kemoterapi ila\u00e7lar\u0131n\u0131n sis \u015feklinde bas\u0131n\u00e7l\u0131 olarak p\u00fcsk\u00fcrt\u00fcld\u00fc\u011f\u00fcn\u00fc ifade etti. Prof. Dr. Koray Topg\u00fcl, “Bu y\u00f6ntem daha az invazivdir, tekrarlanabilir ve ileri evre, cerrahi \u015fans\u0131 olmayan hastalarda bile hastal\u0131\u011f\u0131 kontrol alt\u0131na almada etkilidir. Ayr\u0131ca kar\u0131n i\u00e7i s\u0131v\u0131 birikiminin \u00f6nlenmesinde de fayda sa\u011flar” dedi.<\/p>\n
“Her hasta i\u00e7in multidisipliner de\u011ferlendirme \u015fart”
\n
Ba\u015far\u0131 oranlar\u0131n\u0131n kanser t\u00fcr\u00fcne ve evresine g\u00f6re de\u011fi\u015fti\u011fini vurgulayan Prof. Dr. Koray Topg\u00fcl, over kanserinde ya\u015fam s\u00fcresini anlaml\u0131 \u015fekilde uzatan, mide kanserinde ya\u015fam kalitesini art\u0131ran sonu\u00e7lar elde edildi\u011fini aktard\u0131. Prof. Dr. Koray Topg\u00fcl, “Bu tedaviler mutlaka deneyimli merkezlerde, multidisipliner ekipler taraf\u0131ndan uygulanmal\u0131d\u0131r” ifadelerini kaydederek, periton metastaz\u0131 i\u00e7in art\u0131k umut verici se\u00e7enekler bulundu\u011funu s\u00f6zlerine ekledi.
<\/p>\n","protected":false},"excerpt":{"rendered":"
Kanser tedavisinde son y\u0131llarda geli\u015ftirilen yeni y\u00f6ntemler, kar\u0131n zar\u0131 (periton) metastaz\u0131 olan hastalara umut oluyor. Medicana Sa\u011fl\u0131k Grubu Genel Cerrahi B\u00f6l\u00fcm\u00fc\u2019nden Prof. Dr. Koray Topg\u00fcl, ge\u00e7mi\u015fte tedavisi olduk\u00e7a zor kabul edilen bu hastal\u0131kta HIPEC ve PIPAC ad\u0131 verilen modern uygulamalar sayesinde ya\u015fam s\u00fcresi ve ya\u015fam kalitesinde \u00f6nemli ilerlemeler sa\u011fland\u0131\u011f\u0131n\u0131 s\u00f6yledi. Kanser tedavisinde t\u0131bbi geli\u015fmeler h\u0131zla…<\/p>\n","protected":false},"author":1,"featured_media":55141,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-55140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/55140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55140"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/55140\/revisions"}],"predecessor-version":[{"id":55142,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/55140\/revisions\/55142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/55141"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}